Eli Lilly and Company - Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Links shared publicly online about this topic.
- 1,996total visits
Eli Lilly and Company - Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Eli Lilly and Company - Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
View full resource at newsroom.lilly.com
Tags: Pain, Chronic Pain, Drug, FDA, Eli Lilly and Company
Most Recently Shared on June 3, 2009 at 2:31 pm By:
Lilly Resubmits Cymbalta(R) sNDA for Chronic Pain to FDA http://bit.ly/8n2QD
Advertisement
